Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Study highlights barriers to care, treatment preferences, and interest in research participation in psoriasis in the Latine ...

Discover the hidden inflammation in psoriasis patients' intestines, its link to leaky gut, and the increased risk of Crohn's ...

Psoriasis may also be more severe among Asians because the group tends to have a lower adherence to treatment (not taking or doing treatments as prescribed). Researchers suggest this may be ...

Secukinumab delivers sustained efficacy and quality of life improvements in pediatric generalized pustular psoriasis (GPP).

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

A combination of factors—such as a damaged skin barrier, an abnormal immune system, and psoriasis medications—can allow harmful bacteria, viruses, and fungi to enter the body, leading to a ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.